Company profile for BMI Korea

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We have made pharmaceutical API & formulation into domestic and overseas market since 2005.We're fast-growing pharmaceutical enterprise and have a state-of-the-art facility in Jeju.Since then, we've developed various high-tech injectable product such as Octreotide injection and iron sucrose injection firstly in Korea.Recently we've launched World First 'Highly purified Solutional Hyaluronidase' named 'Hirax-Injection'. Because...
We have made pharmaceutical API & formulation into domestic and overseas market since 2005.We're fast-growing pharmaceutical enterprise and have a state-of-the-art facility in Jeju.Since then, we've developed various high-tech injectable product such as Octreotide injection and iron sucrose injection firstly in Korea.Recently we've launched World First 'Highly purified Solutional Hyaluronidase' named 'Hirax-Injection'. Because Hirax is highly purified and Solutional. So, it's more safe & convenient injection than the others.And, we've developed Low molecular heparin(Enoxaparin) API firstly in Korea.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
Suite 402, Cheongsong-Plaza, 990-2, Cheonggye-Dong, Uiwang-Si
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/brexogen-and-bmi-korea-enter-strategic-technology-transfer-agreement-for-exosome-therapeutics-302378710.html

PR NEWSWIRE
19 Feb 2025

https://www.prnewswire.com/news-releases/bmi-2004-a-recombinant-hyaluronidase-advancing-subcutaneous-drug-delivery---phase-1-clinical-trial-results-to-be-presented-at-the-15th-annual-bioprocessing-summit-in-boston-301898168.html

PR NEWSWIRE
10 Aug 2023

ABOUT THIS PAGE

Contact BMI Korea and get a quotation

BMI Korea is a supplier offers 8 products (APIs, Excipients or Intermediates).

Find a price of Choline Alfoscerate bulk offered by BMI Korea

Find a price of Diacerein bulk offered by BMI Korea

Find a price of Diclofenac Sodium bulk offered by BMI Korea

Find a price of Hyaluronidase bulk offered by BMI Korea

Find a price of Levofloxacin Hemihydrate bulk offered by BMI Korea

Find a price of Sodium DNA bulk offered by BMI Korea

Find a price of Sodium Hyaluronate bulk offered by BMI Korea

Find a price of Telmisartan bulk offered by BMI Korea

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty